A physician attempted to use an evercross pta balloon during treatment of a calcified cto (chronic total occlusion-100%) in the patient's proximal common iliac artery.Moderate vessel tortuosity and severe calcification are reported.A non-medtronic inflation device was used for balloon inflation.There was no damage noted to packaging, i.E.Shelf carton, hoop/tray. there were no issues noted when removing the device from the hoop/tray.The device was prepped as per ifu without issue.The device was not passed through a previously deployed stent.Resistance is reported during advancement of the device.A circumferential/radial balloon burst is reported during inflation at 12 atm.Not all balloon fragments were removed from the patient. a 7x120 entrust everflex stent was used to stent the balloon material in the arterial wall and post dilated with a 7x150 pta balloons.No further injury reported.
|
Image analysis the customer returned an image.The image shows a section of an evercross device.The distal section of the balloon and the luer are missing from the device.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|